Loss of Tight Junction Protein Claudin 18 Promotes Progressive Neoplasia Development in Mouse Stomach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Loss of Tight Junction Protein Claudin 18 Promotes Progressive Neoplasia Development in Mouse Stomach

Published:2018-12 Issue:6 Volume:155 Page:1852-1867
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Hagen Susan J.,Ang Lay-Hong,Zheng Yi,Karahan Salih N.,Wu Jessica,Wang Yaoyu E.,Caron Tyler J.,Gad Aniket P.,Muthupalani Sureshkumar,Fox James G.

Funder

Harvard University

Department of Surgery Bridge

NIH

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference52 articles.

1. Intestinal barriers protect against disease: leaky cell-cell junctions contribute to inflammatory and autoimmune diseases;Citi;Science,2018

2. Helicobacter pylori and gastric cancer: factors that modulate disease risk;Wroblewski;Clin Microbiol Rev,2010

3. Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier;Caron;World J Gastroenterol,2015

4. Comprehensive molecular characterization of gastric adenocarcinoma;Bass;Nature,2014

5. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype;Sanada;J Pathol,2006

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Claudin-18.2 Immunohistochemical Evaluation in Gastric and Gastroesophageal Junction Adenocarcinomas to Direct Targeted Therapy: A Practical Approach;Modern Pathology;2024-11

2. Application of spatial omics in gastric cancer;Pathology - Research and Practice;2024-10

3. Modeling human gastric cancers in immunocompetent mice;Cancer Biology & Medicine;2024-06-28

4. The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer;Expert Opinion on Drug Discovery;2024-06-26

5. Molecular SPECT/CT Profiling of Claudin18.2 Expression In Vivo: Implication for Patients with Gastric Cancer;Molecular Pharmaceutics;2024-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3